BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37496227)

  • 1. [A Patient with AFP-Producing Gastric Cancer and Stenosis Who Regained Oral Intake Capabilities after T-DXd Treatment].
    Amagai H; Sasagawa S; Koide Y; Tsukamoto S; Miyazawa Y; Yamakawa H; Murayama H; Sentsui T; Matsubara H; Yamazaki K; Yarita T
    Gan To Kagaku Ryoho; 2023 Jul; 50(7):813-816. PubMed ID: 37496227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis.
    Yoshida J; Sugiyama K; Satoh M; Shiraishi K; Nishibori R; Kitagawa C
    Curr Probl Cancer; 2021 Dec; 45(6):100757. PubMed ID: 33892964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of HER2-positive and AFP-producing gastric cancer successfully treated by trastuzumab/docetaxel/S-1 combination therapy].
    Amano I; Sawai N; Mizuno C; Shaura Y; Nishiwaki M; Horimoto R; Oya H; Kato R; Seki K; Hashimoto H; Amakata Y; Matsumoto J; Tanaka I; Mizuno M; Shima T; Okanoue T
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2541-4. PubMed ID: 23235175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic Response to Trastuzumab Deruxtecan Rechallenge in a Patient with HER2-Positive Gastric Cancer: A Case Report.
    Ogata T; Fujita Y; Muro K
    Am J Case Rep; 2022 Mar; 23():e935600. PubMed ID: 35241641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective.
    Aoki M; Iwasa S; Boku N
    Gastric Cancer; 2021 May; 24(3):567-576. PubMed ID: 33646464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trastuzumab deruxtecan for the treatment of HER2-positive gastric cancer.
    Mishima S; Shitara K
    Expert Opin Biol Ther; 2021 Jul; 21(7):825-830. PubMed ID: 33798395
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
    Hayashi K; Nagasaki E; Nakada K; Tamura M; Arakawa Y; Uwagawa T; Yano S
    J Infect Chemother; 2018 Apr; 24(4):298-301. PubMed ID: 29174919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of unresectable Stage IV HER2-positive advanced gastric cancer treated by using trastuzumab combined with chemotherapy].
    Aomatsu N; Doi Y; Takemura S; Tanaka H; Muguruma K; Yui S; Hirakawa K
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1316-8. PubMed ID: 25335729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan.
    Yin O; Iwata H; Lin CC; Tamura K; Watanabe J; Wada R; Kastrissios H; AbuTarif M; Garimella T; Lee C; Zhang L; Shahidi J; LaCreta F
    Clin Pharmacol Ther; 2021 Oct; 110(4):986-996. PubMed ID: 33999422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
    Takaya K; Takahashi R; Honma S; Horii S; Takahashi H; Hagiwara M; Chin M; Hashizume E
    Gan To Kagaku Ryoho; 2016 Sep; 43(9):1113-6. PubMed ID: 27628555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells.
    Nakajima S; Mimura K; Matsumoto T; Thar Min AK; Ito M; Nakano H; Neupane P; Kanke Y; Okayama H; Saito M; Momma T; Watanabe Y; Hanayama H; Hayase S; Saze Z; Kono K
    Sci Rep; 2021 Aug; 11(1):16891. PubMed ID: 34413454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer.
    Ishii T; Shitara K
    Expert Rev Anticancer Ther; 2021 Nov; 21(11):1193-1201. PubMed ID: 34543577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of AFP-producing gastric cancer with peritoneal metastasis treated effectively with chemotherapy, mainly using S-1 and trastuzumab].
    Nishiwada S; Watanabe A; Yoshikawa T; Ishioka K; Mukogawa T; Matsusaka M; Ko S; Ishikawa H
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):511-4. PubMed ID: 23848022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of Nivolumab in a Case of Inoperable Advanced Gastric Cancer with Lung Metastasis].
    Takahashi S; Hanaka J; Takahashi M; Okuda Y; Hara A; Yamanaka S; Nakamura Y; Kanamura S; Nakayama H; Goya T
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1251-1253. PubMed ID: 36412030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.
    Shitara K; Iwata H; Takahashi S; Tamura K; Park H; Modi S; Tsurutani J; Kadowaki S; Yamaguchi K; Iwasa S; Saito K; Fujisaki Y; Sugihara M; Shahidi J; Doi T
    Lancet Oncol; 2019 Jun; 20(6):827-836. PubMed ID: 31047804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors.
    Indini A; Rijavec E; Grossi F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy].
    Kuga Y; Kitamura S; Okanobu H; Sakimoto H; Nishida T
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1211-1214. PubMed ID: 27760940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
    Seo S; Suzuki T; Misumi T; Tashiro H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful second conversion surgery after trastuzumab deruxtecan for recurrent HER2-positive gastric cancer.
    Terashima T; Yamashita T; Takabatake H; Nakanuma S; Kinoshita J; Yagi S; Mizukoshi E; Harada K; Fushida S; Kaneko S
    Clin J Gastroenterol; 2023 Jun; 16(3):330-335. PubMed ID: 36708503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of HER2 Positive Gastric Cancer That Was Highly Responsive to Fifth-Line Chemotherapy with Trastuzumab].
    Sato H; Ii T; Hotchi S; Goh K; Rikiyama N; Sato A; Akishige N; Kokumai T; Aoki Y; Kikuchi D; Yamanami H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1646-1648. PubMed ID: 35046284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.